story of the week
Treatment With Ocrelizumab vs Ofatumumab for MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study
J Neurol 2024 May 04;[EPub Ahead of Print], A Zanghì, G Borriello, S Bonavita, R Fantozzi, E Signoriello, S Barone, G Abbadessa, M Cellerino, V Ziccone, G Miele, G Lus, P Valentino, S Bucello, M Inglese, D Centonze, C Avolio, E D'AmicoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.